Based on these findings, we propose that MKRN2 and PPP2CA have opposite regulatory effects on β-Catenin protein expression, leading to functional equilibration of the Wnt signaling that mediates ccRCC tumor progression (Fig. 9). Here, MKRN2 is linked to nonpapillary renal cell carcinoma.